AI tools like DeepLook are improving dense breast cancer detection, while a Cleveland Clinic vaccine trial offers hope for ...

Inavolisib (Itovebi) is a new targeted therapy for HR+ HER2-negative metastatic breast cancer with a PIK3CA mutation.

The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro ...

Patients often don’t realize that the same procedure at different locations (even with the same insurance) can have very ...

Research presented at the ASCO Annual Meeting 2025 highlighted new potential standards of care and other advances in breast cancer.

Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics ...

The Ridley-Tree Cancer Center just launched its new High-Risk Breast Clinic in Santa Barbara. The focus of the new clinic is to ...

Ananda Lewis chose alternative breast cancer treatments for years before her death this month. Here’s what she tried and what ...

Dr Heather McArthur describes how ASCO 2025 showcased new standards of care in triple-negative and HER2-positive settings.

The traditional charity dinner organised by the Marina Baixa Self-Help Group for Women with Breast and Gynaecological Cancer, ...

On the banks of the Schuylkill River in Philadelphia, a group of breast cancer survivors assembles for practice. "My life is ...